Subscribe to RSS - Oncologix


Oncologix increases sales ‘organically’


LAFAYETTE, La. – Oncologix on July 21 reported net revenues of $1.2 million for the three months ended May 31, 2015, compared to $988,000 for the same period last year, a 25% increase.

Oncologix updates on earnings


LAFAYETTE, La. – Oncologix, a diversified medical holding company with operating divisions in medical devices, healthcare services and DME sales and distribution, expects to grow annualized revenues to $25 million by the end of 2015, it announced April 14.

Moneyline: Liberator, Oncologix


Liberator Medical Holdings has approved a quarterly cash dividend of $.0325 per common share payable April 10. This is the ninth cash dividend paid by the Stuart, Fla.-based provider…Oncologix Tech has retired another convertible note.

Oncologix wins with EsteemCare


GRAND RAPIDS, Mich. – Oncologix, a medical holding company, says it has seen increased referrals and revenue growth from its recently acquired subsidiary, EsteemCare, a DME company in South Carolina that is a Medicare contract supplier for respiratory products.

Oncologix makes buy


ALEXANDRIA, La. – Oncologix Tech has acquired Esteemcare and Affordable Medical Equipment Solutions, it announced yesterday.